Compare TNYA & SEVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TNYA | SEVN |
|---|---|---|
| Founded | 2016 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 153.2M | 167.9M |
| IPO Year | 2021 | 2008 |
| Metric | TNYA | SEVN |
|---|---|---|
| Price | $0.41 | $6.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 5 |
| Target Price | $3.20 | ★ $9.55 |
| AVG Volume (30 Days) | ★ 3.7M | 184.2K |
| Earning Date | 11-09-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 16.52% |
| EPS Growth | ★ 54.96 | N/A |
| EPS | N/A | ★ 0.19 |
| Revenue | N/A | ★ $29,383,000.00 |
| Revenue This Year | N/A | $18.67 |
| Revenue Next Year | N/A | $12.98 |
| P/E Ratio | ★ N/A | $35.68 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.36 | $6.70 |
| 52 Week High | $2.02 | $10.90 |
| Indicator | TNYA | SEVN |
|---|---|---|
| Relative Strength Index (RSI) | 26.96 | 42.56 |
| Support Level | N/A | $6.70 |
| Resistance Level | $0.81 | $7.84 |
| Average True Range (ATR) | 0.04 | 0.17 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 23.26 | 37.88 |
Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.
Seven Hills Realty Trust is a real estate investment trust. The company is engaged in originating and investing in floating-rate first mortgage loans secured by middle-market and transitional commercial real estate. Its primary objective is to balance capital preservation with the generation of risk-adjusted returns. The company operates in one business segment: originating and investing in floating-rate first mortgage loans secured by CRE properties.